Company Overview of Nuron Biotech Inc.
Nuron Biotech Inc. develops vaccines and biologics for the prevention and treatment of infectious and neurodegenerative diseases. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was incorporated in 2009 and is based in Exton, Pennsylvania.
1 East Uwchlan Avenue
Exton, PA 19341
Founded in 2009
Key Executives for Nuron Biotech Inc.
Nuron Biotech Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Nuron Biotech Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.